Theravance Biopharma, Inc. (TBPH)
20.37
-0.05
(-0.24%)
USD |
NASDAQ |
Jan 21, 16:00
20.35
-0.02
(-0.10%)
After-Hours: 07:07
Theravance Biopharma Market Cap: 1.032B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.819B |
| Perspective Therapeutics, Inc. | 189.56M |
| Skye Bioscience, Inc. | 31.44M |
| Kyntra Bio, Inc. | 35.33M |
| Myomo, Inc. | 37.43M |
Market Cap Related Metrics
| PE Ratio | 36.21 |
| PS Ratio | 12.78 |
| Price to Book Value | 4.436 |
| Price to Free Cash Flow | 4.218 |
| Price | 20.37 |
| Earnings Yield | 2.76% |
| Normalized PE Ratio | 36.21 |